ADMS
Adamas Pharmaceuticals, Inc.
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
95 hedge funds and large institutions have $391M invested in Adamas Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 30 increasing their positions, 27 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
95
Holders Change
+18
Holders Change %
+23.38%
% of All Funds
2.37%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.1%
New
25
Increased
30
Reduced
27
Closed
6
Calls
$8.72M
Puts
$9.07M
Net Calls
-$346K
Net Calls Change
-$321K
Top Buyers
| 1 |
Millennium Management
New York
|
$26.7M |
| 2 |
KA
Kerrisdale Advisers
Miami,
Florida
|
$16.2M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
$15.9M |
| 4 |
Citadel Advisors
Miami,
Florida
|
$16.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
$18M |
